NEUROCOGNITIVE DISORDERS SEEN IN HIV DISEASE

References

• American Academy of Neurology AIDS Task Force. (1991). Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology, 41, 778–785.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
   Google Scholar
• Asch, S., McCutchan, J. A., Bozette, A., Gifford, A., Winslow, C., & Shapiro, M. (1998). Underuse of primary prophylaxis for mycobacterium avium complex (MAC) in a representative sample of HIV-infected patients in care in the USA: Who is missing the point? (abstract 22167). 12th World AIDS Conference, Geneva, Switzerland.
   Google Scholar
• Astin, J. A. (1998). Why patients use alternative medicine: Results of a national study. Journal of American Medical Association, 279(19), 1548–1553.
   PubMed Web of Science ®Google Scholar
• Bacellar, H., Munoz, A., Miller, E. N., Cohen, B. A., Cohen, B. A., Besley, D., Selnes, 0. A., Becker, J. T., & McArthur, J. C. (1994). Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985–1992. Neurology, 44(10), 1892–1900.
   Google Scholar
• Baker, A. (1997). Dedicated palliative caregivers. Nursing Times, 93(50), 36–37.
   PubMedGoogle Scholar
• Bennett, C. L., Adams, J., Gertler, P., Park, R. E., Gilman, S., George, L., Shapiro, M., & Brook, R. H. (1992). Relation between hospital experience and in-hospital mortality for patients with AIDS-related Pneumocystis carinii pneumonia: Experience from 3,126 cases in New York City in 1987. Journal of Acquired Immune Deficiency Syndromes, 5(9), 856–864.
   PubMed Web of Science ®Google Scholar
• Blair, T., & Ramones, V. (1997). Education as psychiatric intervention: The cognitive-behavioral context. Journal of Psychosocial Nursing, 35(12), 29–36.
   PubMedGoogle Scholar
• Brew, B. J., Brown, S. J., Catalan, J., Sacktor, N., Halman, M., Symonds, W. T., & Romero, C. (1998). Safety and efficacy of abacavir (ABC, 1592) in AIDS demen-tia complex (study CNAB 3001), (abstract 32192). 12th World AIDS Conference, Geneva, Switzerland.
   Google Scholar
• Brew, B. J., Dunbar, N., Pemberton, L., & Kaldor, J. (1996). Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin. Journal of Infectious Diseases, /74(20), 294.–298.
   Google Scholar
• Brodt, H. R., Kamps, B. S., Gute, P., Knupp, B., Staszewski, S., & Helm, E. B. (1997). Changing incidence of AIDS-defining illnesses in the era of antiretroviral combina-tion therapy. AIDS, 11(14), 1731–1738.
   PubMed Web of Science ®Google Scholar
• Cahn, P., Zala, C., Salomon, J., Zirulnik, J., Hodara, V., Vazquez, M., Ochoa, C., & Glancszpigel, R. (1998). Cerebrospinal fluid (CSF) versus plasma HIV RNA levels in patients with AIDS-related neurological diseases (abstract 42170). 12th World AIDS Conference, Geneva, Switzerland.
   Google Scholar
• Carr, A., & Cooper, D. A. (1997). Primary HIV infection. In M. A. Sande & P. A. Volberding (Eds.), The medical management of AIDS (5th ed.), (pp. 89–106) . Philadel-phia: W.B. Saunders.
   Google Scholar
• Centers for Disease Control and Prevention. (1995). HIV/AIDS Surveillance Report, 7\(no. 2), 1–39.
   Google Scholar
• Centers for Disease Control and Prevention. (1996). HIV/AIDS Surveillance Report, 8\(no. 2), 1–39.
   Google Scholar
• Centers for Disease Control and Prevention. (1997a). 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons with human immunodeficiency virus. Morbidity and Mortality Weekly Report, 46(RR-12), 1–46.
   Google Scholar
• Centers for Disease Control and Prevention. (1997b). HIV/AIDS Surveillance Report, 9\(no. 2), 1–43.
   Google Scholar
• Centers for Disease Control and Prevention. (1997c). Update: Trends in AIDS incidence-United States, 1996. Morbidity and Mortality Weekly Report, 46(37), 861–867.
   PubMedGoogle Scholar
• Chambers-Pirro, A., Rloser, P., Johnson, R., Ajuluchrwu, D., Orr, W., Tesoriero, J., Smith, D., Hernandez, L., Sirois, D., Vaughn, A., & Bardeguez, A. (1998). Meet-ing medical standards of care: Ryan White vs. non-Ryan White providers (abstract 60464). 12th World AIDS Conference, Geneva, Switzerland.
   Google Scholar
• Cornelis se, P., Yip, B., Hogg, R. S., Schechter, M. T., 0' Shaughnessy, M. V., & Montaner, J. S. G. (1998). The relationship between AZT therapy and dementia free survival in a province-wide drug treatment program (abstract 32254). 12th World AIDS Con-ference, Geneva, Switzerland.
   Google Scholar
• Dore, G., van der Bij, A., Kaldor, J. M., & Brew, B. J. (1998). Characteristics and prognostic factors for AIDS dementia complex (ADC) (abstract 32220). 12th World AIDS Conference, Geneva, Switzerland.
   Google Scholar
• Dube, M. P., & Sattler, F. R. (1998). Metabolic complications of antiretroviral therapies. AIDS Clinical Care, 10(6), 41–44.
   PubMedGoogle Scholar
• Ferris, F. D., Flannery, J. S., McNeal, H. B., Morissette, M. R., Cameron, R., & Bally, G. A. (1995). A comprehensive guide for the care of persons with HIV disease. Module 4: Palliative care. Toronto, Canada: Mount Sinai Hospital and Casey House Hospice.
   Google Scholar
• Flaskerud, J. H., & Miller, E. N. (1999). Psychosocial and neuropsychiatric dysfunction. In P. J. Ungvarski & J. H. Flaskerud (Eds.), HIV/AIDS: A guide to primary care management (4th ed.), (pp. 255–291). Philadelphia: W. B. Saunders.
   Google Scholar
• Flexner, C. (1998). HIV-protease inhibitors. New England Journal of Medicine, 338(18), 1281–1292.
   PubMed Web of Science ®Google Scholar
• Forstein, M. (1998, September 18). Neuropsychiatric issues for substance using patients with HIV. Presentation at AIDS & addiction: Strategies for clinical management, SUNY Health Science Education Center.
   Google Scholar
• Gisolf, E. H., Portegies, P., Hoetelmans, R., Van der Ende, M. E., Brinkman, K., de Wolf, F., & Danner, S. A. (1998). The effect of ritonavir (RTV)/saquinavir (SQV) versus RTV/SQV/stavudine (d4TO) on cerebral spinal fluid (CSF) HIV-RNA levels: Prelim-inary results (abstract 32197). 12th World AIDS Conference, Geneva, Switzerland.
   Google Scholar
• Harvath, T. A., Patsdaughter, C. A., Bumbalo, J. A., & McCann, M. K. (1995). Dementia-related behaviors in Alzheimer's disease and AIDS. Journal of Psychosocial Nursing, 33(1), 35–39.
   PubMedGoogle Scholar
• Hogg, R. S., Heath, K. V., Yip, V., Craib, K. J., 0' Shaughnes sy, M. V., Schechter, M. T., & Montaner, J. S. (1998). Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. Journal of the American Medical Association, 279(6), 450–454.
   Google Scholar
• Hurley, P. M., & Ungvarski, P. J. (1994a). Home healthcare needs of adults living with HIV disease/AIDS in New York city. Journal of the Association of Nurses in AIDS Care, 5(2), 33–40.
   PubMedGoogle Scholar
• Hurley, P.M., & Ungvarski, P. J. (1994b). Mental health needs of adults with HIV/AIDS referred for home care. Psychosocial Rehabilitation Journal, 17(4), 117–126.
   Google Scholar
• Kaplan, J. E., Amandus, H., van Dyck, K., Greaves, J., Ellis, B., Soto-Torres, L., & Parham, D. (1998). Adherence to opportunistic infections (0Is) prevention guidelines in federally funded health care facilities in the United States. (abstract 42212). 12th World AIDS Conference, Geneva, Switzerland.
   Google Scholar
• Kitahata, M. M., Koepsell, T. D., Deyo, R. A., Maxwell, C. L., Dodge, W. T., & Wagner, E. H. (1996). Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. New England Journal of Medicine, 334(11), 701–706.
   PubMed Web of Science ®Google Scholar
• Laine, C., Markson, L. E., McKee, L. J., Hauck, W. W., Fanning, T. R., & Turner, B. J. (1998). The relationship of clinic experience with advanced HIV and survival of women with AIDS. AIDS, /2(4), 417–424.
   Google Scholar
• McArthur, J. C., Childs, E., Lyles, R. H., Miller, E., Cohen, B. A., Chen, B. B., Mellors, J., & McArthur, J. C. (1998). Predictive markers for HIV-associated dementia and sen-sory neuropathy (abstract 32191). 12th World AIDS Conference, Geneva, Switzer-land.
   Google Scholar
• McBride, A., & Austin, J. (1996). Integrating the behavioral and biological sciences: Implications for practice, education, and research. In A. McBride & J. Austin (Eds.), Psychiatric-mental health nursing: Integrating the behavioral and biological sci-ences (1st ed.), (pp. 425–433). Philadelphia: W.B. Saunders.
   Google Scholar
• McGowan, J. P., & Shah, S. (1998). Long-term remission of AIDS-related primary cen-tral nervous system lymphoma associated with highly active antiretroviral therapy. AIDS, /2(8), 952–954.
   Google Scholar
• McGuire, D., & So, Y. T. (1998). The nervous system in HIV and AIDS. In P. T. Cohen, M. A. Sande, & P. A. Volberding (Eds.), The AIDS knowledge base (3rd ed.), [on-line]. Available: http://hivinsite.ucsf.edu
   Google Scholar
• Moore, R. D., Stanton, D., Gopalan, R., & Chaisson, R. E. (1994). Racial differences in the use of drug therapy for HIV disease in an urban community. New England Journal of Medicine, 330(11), 763–768.
   PubMed Web of Science ®Google Scholar
• Munjas, B., Oliver, C. A., & Luna, B. J. (1998). Psychosocial responses. In M. E. Ropka & A. B. Williams (Eds.), HIV: Nursing and symptom management (1st ed.), (pp. 417–448). Sudbury, MA: Jones and Bartlett Publishers.
   Google Scholar
• Palella, F. J., Jr., Delaney, K. M., Moorman, A. C., Loveless, M. 0., Fuhrer, J., Satten, G. A., Aschman, D. J., & Holmberg, S. D. (1998). Declining morbidity and mor-tality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. New England Journal of Medicine, 338(13), 853–860.
   Google Scholar
• Price, R. W. (1997). Management of the neurologic complications of HIV-1 infection and AIDS. In M. A. Sande & P. A. Volberding (Eds.), The medical management of AIDS (5th ed.), (pp. 197–1216). Philadelphia: W.B. Saunders.
   Google Scholar
• Qureshi, A. I., Hanson, D. L., Jones, J. L., & Janssen, R. S. (1998). Estimation of the temporal probability of human immunodeficiency virus (HIV) dementia after risk adjustment for HIV-infected persons. Neurology, 50(2), 392–397.
   PubMed Web of Science ®Google Scholar
• Resnick, L., Berger, J. R., Shapshak, P., & Tourtellotte, W. W. (1988). Early penetration of the blood-brain barrier by HIV. Neurology, 38(1), 9–14.
   PubMedGoogle Scholar
• Satz, P., Morgenstern, H., Miller, E. N., Selnes, 0., McArthur, J. C., Cohen, B. A., Wes ch, J., Becker, J. T., Jacobson, L., & D'Elia, L. F. (1993). Low education as a possible risk factor for cognitive abnormalities in HIV-1: Findings from the multicenter AIDS cohort study (MACS). Journal of Acquired Immune Deficiency Syndromes, 6(5), 503–511.
   Google Scholar
• Schrager, L. K., & D' Souza, P.M. (1998). Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy. Journal of the American Medical Association, 280(1), 67–71.
   Google Scholar
• Sei, S., Stewart, S. K., Farley, M., Mueller, B. U., Lane, J. R., Robb, M. L., Brouwers, P., & Pizzo, P. A. (1996). Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebral spinal fluid and viral resistance to zidovudine in children with HIV encepaholpathy. Journal of Infectious Diseases, 174(6), 1200–1206.
   PubMedGoogle Scholar
• Selwyn, P. A., Fennie, K. P., Molde, S., Constantino, J., Wetherill, P., Goldman, L., & Kennedy, C. (1998). Palliative care for HIV infection in a skilled nursing facility (abstract 22427). 12th World AIDS Conference, Geneva, Switzerland.
   Google Scholar
• Shafer, R. W., Winters, M. A., Palmer, S., & Merigan, T. C. (1998). Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 iso-lates from heavily treated patients. Annals of Internal Medicine, 128(11), 951–954.
   PubMedGoogle Scholar
• Sidtis, J. J., Dafni, U., Slasor, P., Hall, C., Price, R. W., Kieburtz, K., Tucker, T., & Clifford, D. B. (1997). Stable neurological function in subjects treated with 2'3'-dideoxyinosine. Journal of Neurovirology, 3(3), 233–240.
   PubMed Web of Science ®Google Scholar
• Sidtis, J. J., Gastsonis, C., Price, R. W., Singer, E. J., Collier, A. C., Richman, D. D., Hirsch, M. S., Schaerf, F. W., Fischl, M. A., & Kieburtz, K. (1993). Zidovudine treatment of AIDS dementia complex: Results of a placebo-controlled trial. AIDS clinical trials group. Annals of Neurology, 33(4), 343–349.
   PubMed Web of Science ®Google Scholar
• Skolnick, A. (1998). Protease inhibitors may reverse AIDS dementia. Journal of Amer-ican Medical Association, 279(6), 419.
   PubMedGoogle Scholar
• Staats, J., Sheran, M., & Herr, R. (1999). Adolescents and adults: Care management of AIDS-indicator diseases. In P. J. Ungvarski & J. H. Flaskerud (Eds.), HIV/AIDS: A guide to primary care management (4th ed.), (pp. 194–254). Philadelphia: W. B. Saunders.
   Google Scholar
• Stern, R. A., Silva, S. G., Chaisson, N., & Evans, D. L. (1996). Influence of cognitive re-serve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection. Archives of Neurology, 53,148–153.
   PubMed Web of Science ®Google Scholar
• Stone, V. E., Seage, G. R., Hertz, T., & Epstein, A. M. (1992). The relation between hospital experience and mortality for patients with AIDS. Journal of the American Medical Association, 268(19), 2655–2661.
   Web of Science ®Google Scholar
• Stone, V., Steger, K. A., Hirschhorn, L. R., Boswell, S. L., Stein, M. D., Duefield, C. A., Mayer, K. H., Clarke, J. G., Monroe, A. D., & Poses, R. M. (1998). Access to treatment with protease inhibitor (PI) containing regimens: Is it equal for all? (abstract 42305). 12th World AIDS Conference, Genva, Switzerland.
   Google Scholar
• Thomas, R. I., & Varas, E. (1998). Cognitive function improvements accompanying combination anti-retroviral therapy (abstract 32255). 12th World AIDS Conference, Geneva, Switzerland.
   Google Scholar
• Turner, B. J., & Ball, J. K. (1992). Variations in inpatient mortality for AIDS in a national sample of hospitals. Journal of Acquired Immune Deficiency Syndromes, 5(10), 978–987.
   PubMed Web of Science ®Google Scholar
• Ungvarski, P. J. (1994). Comorbidities of HIV-1/AIDS in adults. Journal of the Associ-ation of Nurses in AIDS Care, 5(6), 20–29.
   Google Scholar
• Ungvarski, P. J., Angell, J., Lancaster, D. J., & Manlapaz, J. P. (1999). Adolescents and adults: HIV disease care management. In P. J. Ungvarski & J. H. Flaskerud (Eds.), HIV/AIDS: A guide to primary care management (4th ed.), (pp. 131–193). Philadelphia: W. B. Saunders.
   Google Scholar
• Ungvarski, P. J., & Rottner, J. E. (1997). Errors in prescribing HIV-1 protease inhibitors. Journal of the Association of Nurses in AIDS Care, 8(4), 55–61.
   PubMedGoogle Scholar
• van Servellen, G. (1996). Persons with AIDS. In K. M. Fortinash, & P. A. Holoday-Worret (Eds.), Psychiatric mental health nursing (1st ed.), (pp. 654–665). St. Louis, MO: Mosby.
   Google Scholar
• Wainberg, M. A., & Friedland, G. (1998). Public health implications of antiretroviral therapy and HIV drug resistance. Journal of the American Medical Association, 279(24), 1977–1983.
   PubMed Web of Science ®Google Scholar
• Whipple, B., & Walsh-Scura, K. (1996). The overlooked epidemic: HIV in older adults. American Journal of Nursing, 96(2), 23–28.
   Web of Science ®Google Scholar
• Wilbur, S., & Arns, P. (1998). Psychosocial rehabilitation nurses: Taking our place on the multidisciplinary team. Journal of Psychosocial Nursing, 36(4), 33–41.
   PubMedGoogle Scholar
• Wiley, C., Soontornniyomkis, V., Achim, C., Mellors, I., Masliah, E., Hermann, S., & Dailey, P. (1998). Distribution of brain HIV in AIDS (abstract 32203). 12th World AIDS Conference, Geneva, Switzerland.
   Google Scholar